Esculentoside A T3877
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Esculentoside A can suppress inflammatory responses in LPS-induced ALI through inhibition of the NF-_B and mitogen-activated protein kinase signaling pathways. Esculentoside A may be useful for the treatment of autoimmune disease through modulation on T c
CAS nr:
65497-07-6
Purity:
98%
Molecular Weight:
826,96
SMILES:
[C@@H]1([C@H](C[C@]2([C@H]([C@@]1(CO)C)CC[C@@]1(C)[C@]3(C)CC[C@@]4(C(=O)O)CC[C@](C)(C(=O)OC)C[C@H]4C3=CC[C@H]21)C)O)O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@H](O2)CO)CO1
Formula:
C42H66O16
Pathway:
Immunology/Inflammation,NF-_b,Neuroscience
Target:
COX,NF-_B,COX
